EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence

Ankit Kumar, Bikash Kumar Sah, Faiz Ahmad, Vishal Jamwal, Sanjeev Kumar Sahu iD

Phytotherapy Research · 2026-08 · 40 (8) · 4913-4931

DOI: 10.1002/ptr.70158 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 08.01.2026. Verfasst von Ankit Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India. Hauptthemen laut MEDLINE: Withania, Plant Extracts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ashwagandha ( Withania somnifera ) is a herbal adaptogen which has been extensively studied for its wide‐ranging medicinal properties, ranging from stress relief to neuroprotection and immune modulation. Recent studies have evoked concerns over the toxicity of the bioactive compounds, including withanolides, alkaloids, and sitoindosides. Gastrointestinal side effects, immune hypersensitivity, liver toxicity, and endocrine disruption have been reported, particularly with prolonged or excessive usage. Metabolic transformation via cytochrome P450 enzymes can form reactive intermediates, leading to oxidative stress and hepatotoxicity. The endocrine‐modulating activity of Ashwagandha has been implicated in thyrotoxicosis and adrenal suppression. This review provides a comprehensive overview of the pharmacological profiles, incorporating preclinical and clinical data to illustrate the fine balance between the therapeutic and toxic effects of Ashwagandha, identifying populations that may be at increased risk of adverse reactions and interactions with prescribed drugs for specific conditions. The necessity for standardizing dosing regimens, rigorous clinical trials, improving pharmacovigilance, carrying out long‐term safety assessments, and revising regulatory guidelines is emphasized to maximize clinical application of Ashwagandha while minimizing concomitant risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WithaniaPlant ExtractsHumansAnimalsWithanolides

Stichwörter der Autor:innen

Withania somniferaadverse effectsbiological potentialclinical safetyendocrine dysfunctionherb–drug interactions

Substanzen

AshwagandhaPlant ExtractsWithanolides

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

ORCID-Profile: Sanjeev Kumar Sahu

Zitieren

APA

Kumar, A., Sah, B. K., Ahmad, F., Jamwal, V., & Sahu, S. K. (2026). Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence. Phytotherapy Research, 40(8), 4913-4931. https://doi.org/10.1002/ptr.70158

Vancouver

Kumar A, Sah BK, Ahmad F, Jamwal V, Sahu SK. Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence. Phytotherapy Research. 2026;40(8):4913-4931. doi:10.1002/ptr.70158

BibTeX
@article{Kumar2026,
  author = {Kumar, Ankit and Sah, Bikash Kumar and Ahmad, Faiz and Jamwal, Vishal and Sahu, Sanjeev Kumar},
  title = {Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {4913--4931},
  doi = {10.1002/ptr.70158}
}
Kostenlos starten →